Netti C, Guidobono F, Sibilia V, Cazzamalli E, Villa I, Pecile A
Dept. of Pharmacology, Chemotherapy and Medical Toxicology, University of Milan, Italy.
Agents Actions. 1989 Apr;27(1-2):117-9. doi: 10.1007/BF02222215.
We examined the effects of an irreversible inhibitor of brain histamine (HA) synthesis, alpha-fluoromethyl-histidine (alpha-FMH), on prolactin (PRL) release induced by an opiate agonist (morphine, M) or by a serotonergic agonist (MK212). alpha-FMH was administered intracerebroventricularly (i.c.v., 200 micrograms/rat) into freely moving rats with indwelling catheters in the carotid. M (6 mg/kg, intracarotid, i.a.) was administered simultaneously with or 3 h after alpha-FMH. MK212 (2.5 mg/kg, i.a.) was administered 3 h after alpha-FMH. Blood samples for assay for PRL were drawn at 0, 10, 20, 40 min after M or MK212 administration. alpha-FMH (3 h before) significantly reduced the PRL-releasing effect of M and MK212 but did not modify PRL release by M when administered simultaneously. The present results showing that the facilitatory actions of the opiate and serotonergic systems on PRL are impaired when brain HA synthesis is reduced, suggest that there is an HA-dependent step in opiate and serotonergic control of PRL.
我们研究了脑组胺(HA)合成的不可逆抑制剂α-氟甲基组氨酸(α-FMH)对阿片类激动剂(吗啡,M)或5-羟色胺能激动剂(MK212)诱导的催乳素(PRL)释放的影响。将α-FMH经脑室内(i.c.v.,200微克/大鼠)给予颈动脉内置有导管的自由活动大鼠。M(6毫克/千克,经颈动脉,i.a.)与α-FMH同时或在α-FMH给药3小时后给药。MK212(2.5毫克/千克,i.a.)在α-FMH给药3小时后给药。在给予M或MK212后的0、10、20、40分钟采集血样用于检测PRL。α-FMH(提前3小时)显著降低了M和MK212的PRL释放效应,但同时给药时并未改变M诱导的PRL释放。目前的结果表明,当脑HA合成减少时,阿片类和5-羟色胺能系统对PRL的促进作用受损,这表明在阿片类和5-羟色胺能对PRL的控制中存在一个依赖HA的步骤。